Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay-Reference-Cited by-同舟云学术

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay

Published:2015-11-10 Issue:3 Volume:5 Page:e1100791
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Verronèse E.,Delgado A.,Valladeau-Guilemond J.,Garin G.,Guillemaut S.,Tredan O.,Ray-Coquard I.,Bachelot T.,N'Kodia A.,Bardin-Dit-Courageot C.,Rigal C.,Pérol D.,Caux C.,Ménétrier-Caux C.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1100791

Reference63 articles.

1. High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates

2. Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

3. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

4. Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

5. Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients;OncoImmunology;2024-06-26

2. Peripheral immunophenotyping reveals lymphocyte stimulation in healthy women living with hereditary breast and ovarian cancer syndrome;iScience;2024-06

3. Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement;BMC Immunology;2024-05-03

4. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers;Science Translational Medicine;2024-01-24

5. Engineering immune response to regulate cardiovascular disease and cancer;Advances in Protein Chemistry and Structural Biology;2024